Type d'article
Etat
Reliure
Particularités
Livraison gratuite
Pays
Evaluation du vendeur
Edité par Springer, 2012
ISBN 10 : 146144117XISBN 13 : 9781461441175
Vendeur : GreatBookPrices, Columbia, MD, Etats-Unis
Livre
Etat : New.
Edité par Springer, 2012
ISBN 10 : 146144117XISBN 13 : 9781461441175
Vendeur : booksXpress, Bayonne, NJ, Etats-Unis
Livre
Hardcover. Etat : new.
Edité par Springer, 2012
ISBN 10 : 146144117XISBN 13 : 9781461441175
Vendeur : Lucky's Textbooks, Dallas, TX, Etats-Unis
Livre
Etat : New.
Edité par Springer, 2012
ISBN 10 : 146144117XISBN 13 : 9781461441175
Vendeur : Ria Christie Collections, Uxbridge, Royaume-Uni
Livre impression à la demande
Etat : New. PRINT ON DEMAND Book; New; Fast Shipping from the UK. No. book.
Edité par Springer, 2012
ISBN 10 : 146144117XISBN 13 : 9781461441175
Vendeur : GreatBookPricesUK, Castle Donington, DERBY, Royaume-Uni
Livre
Etat : New.
Edité par Springer US Sep 2012, 2012
ISBN 10 : 146144117XISBN 13 : 9781461441175
Vendeur : BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Allemagne
Livre impression à la demande
Buch. Etat : Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -This book highlights progress and trends in the rapidly evolving field of complement-related drug discovery and spotlights examples of clinical applications. As an integral part of innate immunity and critical mediator in homeostatic and inflammatory processes, the human complement system has been identified as contributor to a large number of disorders including ocular, cardiovascular, metabolic, autoimmune, and inflammatory diseases as well as in ischemia/reperfusion injury, cancer and sepsis. In addition, complement is often involved in adverse immune reactions to biomaterials, cell and organ transplants or drug delivery systems. Although the complement cascade with its close to 50 extracellular protein targets has long been recognized as an attractive system for therapeutic modulation, the past few years have seen a particularly strong boost in interest. Fueled by novel research insight and the marketing of the first complement-targeted drugs, a plethora of highly creative treatment approaches and potent drug candidates have recently emerged and are currently evaluated in disease models and clinical trials. The chapters in this book cover a wide range of topics related to the development of complement therapeutics, ranging from the molecular and functional description of complement targets to the presentation of novel inhibitors, improved treatment strategies as well as examples of disease models and clinical applications. The broad and up-to-date overview on a highly versatile and dynamic field renders this book an indispensable source of information for researchers and clinicians dealing with therapeutic and disease-related aspects of the human complement system. 328 pp. Englisch.
Edité par Springer US, 2012
ISBN 10 : 146144117XISBN 13 : 9781461441175
Vendeur : moluna, Greven, Allemagne
Livre impression à la demande
Gebunden. Etat : New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Proceedings from the 5th International Complement Theraputics ConferencePart of the Aegean Conferences seriesIncorporates cutting-edge research and showcases methods developed and perfected in the last decadeProgress and Trends in C.
Edité par Springer US, 2012
ISBN 10 : 146144117XISBN 13 : 9781461441175
Vendeur : AHA-BUCH GmbH, Einbeck, Allemagne
Livre
Buch. Etat : Neu. Druck auf Anfrage Neuware - Printed after ordering - This book highlights progress and trends in the rapidly evolving field of complement-related drug discovery and spotlights examples of clinical applications. As an integral part of innate immunity and critical mediator in homeostatic and inflammatory processes, the human complement system has been identified as contributor to a large number of disorders including ocular, cardiovascular, metabolic, autoimmune, and inflammatory diseases as well as in ischemia/reperfusion injury, cancer and sepsis. In addition, complement is often involved in adverse immune reactions to biomaterials, cell and organ transplants or drug delivery systems. Although the complement cascade with its close to 50 extracellular protein targets has long been recognized as an attractive system for therapeutic modulation, the past few years have seen a particularly strong boost in interest. Fueled by novel research insight and the marketing of the first complement-targeted drugs, a plethora of highly creative treatment approaches and potent drug candidates have recently emerged and are currently evaluated in disease models and clinical trials. The chapters in this book cover a wide range of topics related to the development of complement therapeutics, ranging from the molecular and functional description of complement targets to the presentation of novel inhibitors, improved treatment strategies as well as examples of disease models and clinical applications. The broad and up-to-date overview on a highly versatile and dynamic field renders this book an indispensable source of information for researchers and clinicians dealing with therapeutic and disease-related aspects of the human complement system.
Edité par Springer Verlag, 2012
ISBN 10 : 146144117XISBN 13 : 9781461441175
Vendeur : Revaluation Books, Exeter, Royaume-Uni
Livre
Hardcover. Etat : Brand New. 1st edition. 320 pages. 10.25x7.50x0.75 inches. In Stock.
Edité par Springer-Verlag New York Inc., 2012
ISBN 10 : 146144117XISBN 13 : 9781461441175
Vendeur : Kennys Bookshop and Art Galleries Ltd., Galway, GY, Irlande
Livre
Etat : New. Following on the Aegean Conference on Complement Therapeutics, this book offers expert focus on contemporary and emerging aspects of complement-mediated disease pathogenesis and the development of therapeutics that modulate this system in a beneficial manner. Editor(s): Lambris, John D.; Holers, V.Michael; Ricklin, Daniel. Series: Advances in Experimental Medicine and Biology. Num Pages: 320 pages, biography. BIC Classification: MJCM. Category: (P) Professional & Vocational. Dimension: 254 x 178 x 23. Weight in Grams: 812. . 2012. Hardback. . . . .
Edité par Springer, 2012
ISBN 10 : 146144117XISBN 13 : 9781461441175
Vendeur : GreatBookPricesUK, Castle Donington, DERBY, Royaume-Uni
Livre
Etat : As New. Unread book in perfect condition.
Edité par Springer, 2012
ISBN 10 : 146144117XISBN 13 : 9781461441175
Vendeur : Mispah books, Redhill, SURRE, Royaume-Uni
Livre
Hardcover. Etat : Like New. Like New. book.
Edité par Springer, 2012
ISBN 10 : 146144117XISBN 13 : 9781461441175
Vendeur : GreatBookPrices, Columbia, MD, Etats-Unis
Livre
Etat : As New. Unread book in perfect condition.
Edité par Springer-Verlag New York Inc., 2012
ISBN 10 : 146144117XISBN 13 : 9781461441175
Vendeur : Kennys Bookstore, Olney, MD, Etats-Unis
Livre
Etat : New. Following on the Aegean Conference on Complement Therapeutics, this book offers expert focus on contemporary and emerging aspects of complement-mediated disease pathogenesis and the development of therapeutics that modulate this system in a beneficial manner. Editor(s): Lambris, John D.; Holers, V.Michael; Ricklin, Daniel. Series: Advances in Experimental Medicine and Biology. Num Pages: 320 pages, biography. BIC Classification: MJCM. Category: (P) Professional & Vocational. Dimension: 254 x 178 x 23. Weight in Grams: 812. . 2012. Hardback. . . . . Books ship from the US and Ireland.